Invention Grant
- Patent Title: Noninvasive assessment of cardiac resynchronization therapy
-
Application No.: US15643172Application Date: 2017-07-06
-
Publication No.: US11253178B2Publication Date: 2022-02-22
- Inventor: Robert W. Stadler , Subham Ghosh
- Applicant: Medtronic, Inc.
- Applicant Address: US MN Minneapolis
- Assignee: Medtronic, Inc.
- Current Assignee: Medtronic, Inc.
- Current Assignee Address: US MN Minneapolis
- Agency: Mueting Raasch Group
- Main IPC: A61B5/02
- IPC: A61B5/02 ; A61B5/15 ; A61B5/00 ; A61N1/362 ; A61N7/02 ; A61B5/11 ; A61B5/282 ; A61B5/366 ; A61N7/00 ; A61B5/30

Abstract:
Systems, methods, and interfaces are described herein for noninvasively determining an optimal coronary sinus branch to cannulate for a medical electrical lead. One exemplary method involves applying an electrode apparatus having a plurality of electrodes to a torso of a patient. One of a right ventricular (RV) lead is introduced to a right ventricle or a right atrial (RA) lead is introduced to a right atrium. Noninvasively ultrasonic energy is introduced to a target tissue selected from a set of target tissues. In response to delivering ultrasonic energy to the cardiac tissue, a processing unit receives a torso-surface potential signal from each of a plurality of electrodes distributed on a torso of a patient for the target tissue. Signals are sensed from one of the RA lead and the RV lead in response to delivering ultrasonic energy. For at least a subset of the plurality of electrodes, calculating, with the processing unit, a torso-surface activation time based on the signal sensed from the electrode. Determining whether the tissue site or the another tissue site provides optimal cardiac resynchronization.
Public/Granted literature
- US20170303840A1 NONINVASIVE ASSESSMENT OF CARDIAC RESYNCHRONIZATION THERAPY Public/Granted day:2017-10-26
Information query